Latest Autoinjector Stories

DALLAS, June 19, 2013 /PRNewswire/ -- The Report "European Drug Delivery Technology Market (Metered Dose Inhalers, Needle-free Injectors, Auto-injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017" analyzes and studies the major market drivers, restraints and opportunities in the following Regions: - Germany - France - United Kingdom -...

Includes the latest, most innovative products, images and videos from inside Unilife YORK, Pa., June 18, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), a U.S. based designer, developer and manufacturer of injectable drug delivery systems, today announced the launch of its new corporate website at www.unilife.com. The new site includes additional products, videos, features, blogs and other information, with updates to occur on a regular...

Inspired by the millions of people who have made EpiPen® (epinephrine) Auto-Injector the No. 1 prescribed epinephrine auto-injector for 25 years, Mylan Specialty's anniversary campaign educates, engages and gives back to the allergy community BASKING RIDGE, N.J., June 18, 2013 /PRNewswire/ -- Pro football player and 2012 most valuable player (MVP) Adrian Peterson and professional family expert Jo Frost have potentially life-threatening (severe) allergies and are partnering with...

“Disposable Syringe Markets” & “Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” Dallas, Texas (PRWEB) June 10, 2013 This report “Disposable Syringe Markets” examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and...

DUBLIN, June 7, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cw4qfd/autoinjectors_to) has announced the addition of the "Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect" [http://www.researchandmarkets.com/research/cw4qfd/autoinjectors_to ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) While autoinjectors are sometimes designed to work...

In support of National Asthma and Allergy Awareness Month, Mylan goes to bat to help baseball fans with peanut allergies enjoy one of America's favorite pastimes BASKING RIDGE, N.J., May 29, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), today announced it is partnering with an all-star roster of baseball teams to host Allergy Awareness games at select stadiums across the country. Mylan Specialty, the...

FARMINGTON, Conn., May 17, 2013 /PRNewswire-iReach/ -- The escalation of new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Alternate delivery technologies are on the rise as a number of factors are converging to create both risk and opportunity for pharmaceutical makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward...

Marketer of EpiPen® Auto-Injector, the No. 1 prescribed epinephrine auto-injector, announces additional efforts to increase anaphylaxis awareness, preparedness and access to treatment for those affected by life-threatening allergies BASKING RIDGE, N.J., April 25, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), is celebrating the 25(th) anniversary of the U.S. Food and Drug Administration's (FDA) approval...

YORK, Pa., April 18, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced the development of the Unifill Assure((TM)), a customized device from its Unifill(®) platform of ready-to-fill (prefilled) syringes that is designed to address unmet market needs for the injection of high-viscosity biologic drugs by patient populations with reduced dexterity. Mr. Michael Ratigan, Chief Commercial Officer of Unilife, said, "The Unifill...

15-Year Contract Expected to Generate up to $110 Million, with Revenue Starting Immediately YORK, Pa., April 9, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS) today announced the signing of a Customization and Commercial Supply Agreement with a U.S. pharmaceutical company (the "Customer") for the EZMix((TM)) dual-chamber syringe. (Photo: http://photos.prnewswire.com/prnh/20130409/NY91030 ) Unilife will supply the Customer with a...